First Blood Test for Alzheimer Disease Available in U.S.
Test from C2N Diagnostics is meant for people 60 years and older who have cognitive issues and are being assessed for Alzheimer disease
Delirium Common in Seniors Presenting to ED With COVID-19
Delirium is the sixth most common presenting symptom/sign; delirium linked to ICU stay and death
RSNA: Anxiety May Hasten Progression to Alzheimer Disease
Rate of progression from MCI to AD increased with ApoE4, anxiety, lower hippocampal and entorhinal cortex volumes
RSNA: Neurologic Complications of COVID-19 Examined
In patients with critical findings identified on neuroimaging, most common comorbidities were hypertension, diabetes
Non-COVID-19-Related Deaths Up, Too
Excess deaths seen for specific gender and age groups, with protective effect seen for female children
Cognitive Exercises May Lower Risk for Postoperative Delirium
Cognitive prehabilitation reduced delirium among older adults undergoing major noncardiac surgery
Predictors of Late Effects in Young AML Survivors Explored
Most common late effects were endocrine, cardiovascular, respiratory; likelihood of late effects up for those who underwent HSCT
Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk
Air Pollution May Up Alzheimer Disease Risk in Elderly
Association seen in older women persisted even at PM2.5 levels below U.S. regulatory standards
